Steven Hutchins appointed as President and Dr. Takeshi Yura as Vice President
Jubilant Biosys recent announced two new leadership appointments. Steven Hutchins has been appointed as the President and Dr Takeshi Yura has been appointed as the Vice President of Medicinal Chemistry.
Hutchins brings 26 years of pharmaceutical and healthcare experience and leadership to Jubilant including experience in business development, R&D and strategic partnerships. He has held senior management positions at Merck, BioDuro, WuXi AppTec and Evotec where he was leading the development of strategy, sales and marketing and commercialisation of key strategic alliances.
Dr Yura has 28 years of experience in medicinal and organic chemistry. He had held various scientific positions at Tanabe Saiyaku, Bayer Yakuhin, Pfizer Nagoya Laboratories and Dishman Japan. Before joining Jubilant, he held a senior leadership position at AMRI as Vice President of Discovery and Development Services for Asia and General Manager of Singapore Research Centre.
EP News Bureau